Rapid, structure-free binding affinity prediction enables OpenFold3 to address key bottleneck in commercial early-stage drug discovery PALO ALTO, Calif., Jan. 20, 2026 /PRNewswire/ -- SandboxAQ today ...

Virtual screen of 10,000 proteins and 500 million compounds takes just a day, delivers 2 million small-molecule hits ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Many natural compounds that act on the human body provide active ingredients for medicines or clues for developing them, and ...

Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Figure 1. This figure depicts the four categories of protein druggability target screening tools discussed in this section, which include structure-based methods, sequence-based methods, machine ...

In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

Researchers from the University of Cincinnati College of Medicine and Cincinnati Children's Hospital have found a new method to increase both speed and success rates in drug discovery. The study, ...